The Christie NHS FT Annual Report & Accounts 2019-20

The Christie NHS Foundation Trust Annual Report & Accounts 2019-20

England through its regional teams, according to NHSE’s Emergency Preparedness, Resilience and Response Framework. As a result we implemented our incident response plans aimed at managing the risk. We also participated in the Great Manchester & Cheshire Hospital Cell in order to be part of a coordinated and sustained response. We have not identified any principal risks to compliance with the NHS Provider licence and throughout the 2019-20 financial year, the Trust has achieved a score of 1 for Use of Resources and 1 for Governance, the best scores possible. We have a mature risk and quality management system as tested by the CQC in the 2018 inspection. The inspection rated us as Outstanding for the core standards reviewed and the well led domain. Board sub committees of Audit and Quality Assurance are wholly non-executive director led and have an annual work plan which also includes a review of the committee’s effectiveness. There are strong reporting lines and the minutes of the meeting and any escalations are formally reviewed at the Board of Directors meeting. Executives are only in attendance at these Board assurance committees. The reports provided to the audit and quality assurance committees are, in the main, audits that have been carried out by the internal audit function and this provides the Board with independent assurance.

radiotherapy staff. We have identified this could lead to a negative impact on engagement levels and the delivery of services. The risk is currently scored as a 16 on our risk register and there are a range of actions in place to ensure recruitment and retention work programmes are in place. The Trust is also part of the NHSI recruitment and retention collaborative. An increase in demand for diagnostic testing and issues with staffing created delays in the reporting of CT scans. This resulted in a risk to patient experience; possible delays in the delivery of care and treatment, and potential for patients to remain on treatments which are no longer effective. This risk was scored as a 20. The backlog of CT scans was prioritised and managed to ensure that all scans were reported and processes put in place to ensure the reporting is managed in a timely way going forward. Across the course of the year there was a regular failure of supply of the radiopharmaceutical tracer, FDG, used in PET CT scanning. This resulted in delays in patient's scans, increased probability of breaches of national targets, breaches of research protocols and damage to the Trust’s reputation. This risk was scored at 16. The issues with supply have been rectified in the later months of the year. On 16 th March NHSE declared a level 4 incident in response to the global pandemic of COVID-19. This allows NHSE’s national team to direct all health service resources in

144